Pituitary Apoplexy May Be Mistaken for Temporal Arteritis by Pedro, B et al.
European Journal
of Case Reports in
Internal Medicine
DOI: 10.12890/2019_001261 European Journal of Case Reports in Internal Medicine © EFIM 2019
Doi: 10.12890/2019_001261 - European Journal of Case Reports in Internal Medicine - © EFIM 2019
 
Pituitary Apoplexy May Be Mistaken for Temporal Arteritis
Bárbara Pedro, Tereza Patrícia, Fernando Aldomiro
Hospital Professor Doutor Fernando Fonseca, Serviço de Medicina II, Amadora, Portugal
Received: 24/08/2019
Accepted: 17/09/2019
Published: 16/10/2019
How to cite this article: Pedro B, Patricía T, Aldomiro F. Pituitary apoplexy may be mistaken for temporal arteritis. EJCRIM 2019;6: 
doi:10.12890/2019_001261.
Conflicts of Interests: The Authors declare that there are no competing interest 
This article is licensed under a Commons Attribution Non-Commercial 4.0 License
ABSTRACT
Pituitary apoplexy is a rare endocrine emergency, characterized by a sudden increase in pituitary gland volume secondary to acute ischaemic 
infarction or haemorrhage of the pituitary gland, usually in the presence of a pituitary adenoma. We present the case of a 79-year-old man 
admitted for new-onset, bi-temporal and severe headache, associated with photophobia and vomiting, whose additional study revealed 
pituitary apoplexy. This case highlights the need for high clinical suspicion of this rare entity in order to reduce the associated mortality.
LEARNING POINTS
• Pituitary apoplexy can present with severe headache without ophthalmoplegia or impairment of consciousness.
• It may be mistaken for temporal arteritis.
• CT may be normal so MRI is the diagnostic imaging of choice.
KEYWORDS
Pituitary apoplexy, adenoma, corticosteroids
CASE DESCRIPTION 
A 79-year-old man was admitted to hospital with new-onset, bi-temporal and severe headache, associated with photophobia and vomiting. 
The patient denied visual disturbances, jaw claudication and other focal neurological symptoms. He was fully conscious, afebrile and 
haemodynamically stable. Funduscopic examination showed a well-defined optic disk and a visible bilateral venous pulse. The patient’s 
erythrocyte sedimentation rate was high (84 mm/h) and serum sodium level was low (133 mmol/l). A brain CT scan was normal. 
Given the clinical suspicion of giant cell arteritis, despite the need for exclusion of cerebral venous thrombosis, the patient started 
prednisolone 40 mg per day and acetylsalicylic acid 100 mg per day, and a temporal artery biopsy was scheduled. MRI showed the pituitary 
gland was slightly increased in size and pituitary function tests indicated low ACTH, LH, prolactin and testosterone (Table 1). MRI directed 
to the sella turcica showed the gland was increased in size due to an enlarged adenohypophysis, with alterations compatible with pituitary 
apoplexy, but the optic chiasm was preserved (Fig. 1). Temporal artery biopsy failed to find any lesions compatible with giant cell arteritis. 
The patient stopped prednisolone and started hydrocortisone, with careful control of fluids and electrolyte balance and conservative non-
surgical management.
DISCUSSION
Pituitary apoplexy is a potentially life-threatening condition caused by infarction or haemorrhage of the pituitary gland. Pearce Bailey 
described the first case of pituitary tumour-associated haemorrhage in 1898, but the term pituitary apoplexy was first coined by Brougham 
et al. in 1950. Pituitary apoplexy occurs in 0.6–10% of treated pituitary adenomas, and 0.2–0.6 events occur per 100 person-years in non-
functioning pituitary adenomas. 
European Journal
of Case Reports in
Internal Medicine
DOI: 10.12890/2019_001261 European Journal of Case Reports in Internal Medicine © EFIM 2019
Figure 1. Non-enhanced MRI image (T1) showing a large pituitary gland mainly due 
to an enlarged adenohypophysis
Most patients present in the fifth or sixth decade of life and there is a slight male preponderance ranging from 1.1 to 2.25:1.0. Mostly, the 
primary event involves an adenoma, but pituitary apoplexy may also occur in non-adenomatous or even a normal pituitary gland, especially 
during pregnancy. The precise pathophysiology is not completely understood, but a proposed hypothesis involves tumour vascular reduction 
or occlusion due to tumour growth, with an increase in intrasellar pressure. 
Precipitating factors can be identified in only about 40% of cases, with arterial hypertension being the most common predisposing factor [1–3].
The clinical presentation is variable, with the most frequent presentation being severe headache, visual defects, ophthalmoplegia and 
impairment of consciousness. The symptoms are related to anatomical structures in the proximity of the pituitary gland which are prone to 
compression due to tumour expansion [1, 3].
Brain imaging is required to identify a pituitary lesion and although a cranial CT scan is easier to obtain, it is less sensitive for the diagnosis 
of pituitary lesions, so MRI is the diagnostic imaging modality of choice. Additionally, evaluation of pituitary hormones is required and 
nearly 80% of patients will have deficiency of at least one of the anterior pituitary hormones at presentation. Clinically, the most important 
endocrine dysfunction is adrenocorticotropic hormone (ACTH) deficiency, reported in up to 70% of cases.
The immediate medical management of patients with pituitary apoplexy includes careful assessment of fluids and electrolyte balance, 
replacement of corticosteroids, and supportive measures to ensure haemodynamic stability. Neurosurgical decompression should be 
considered in patients with severe visual impairment, and long-term hormonal replacement therapy is needed in about 80% of patients [4, 5].
Results Normal range
TSH 0.463 mUI/L 0.350–5.500
Prolactin 0.77 ng/mL 2.1–17.7
ACTH 4.49 pg/mL 4.70–48.80
LH 0.28 mUI/mL 3.1–34.6
FSH 2.2 mUI/mL 1.4–18.1
GH 0.45 ng/mL 0.02–4.77
Cortisol 17.6 μg/dL 4.30–22.40
Table 1. Results of baseline anterior pituitary function tests
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